Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 16, 2025

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that …

Aya Gold & Silver Announces Completion of Strategic Transaction with Mx2 Mining
MONTREAL, April 16, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce the successful closing of the previously announced strategic transaction with Mx2 Mining Inc. (“Mx2”), which …

Spectral Medical Completes Tigris Trial Enrollment
157 patients enrolled Topline results expected to be released in August 2025 Company to host Corporate Update Call on May 15, 2025 TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage …

Calibre Reminds SecurityHolders to Vote For the Combination with Equinox
Deadline to vote your shares and stock options is Tuesday, April 22, 2025 at 10:00 a.m. (Vancouver time) The Board of Directors of Calibre recommends that Securityholders vote FOR the Arrangement Resolution. Leading independent proxy advisory firm has …

Discovery Completes Acquisition of Porcupine Complex, Emerges as New Canadian-Based Gold Producer
Growing gold production in one of the world’s most prolific mining camps Large Mineral Resource base with substantial exploration upside A management team with extensive experience working in the Timmins Camp Increased financial strength following closing …

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA® is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize …

La subsidiaria ZenaDrone de ZenaTech ofrece una actualización sobre el proceso de certificación Green UAS para el dron IQ Square diseñado para estudios de levantamiento topográfico, inspecciones de puentes y otras aplicaciones de defensa en EE. UU.
VANCOUVER, Columbia Británica, April 15, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), una empresa de tecnología especializada en drones con IA (Inteligencia Artificial), Dron como un Servicio (DaaS), …

Proto Hologram Expands in India with Amitabh Bachchan & Sourav Ganguly
Hyderabad, India, April 15, 2025 (GLOBE NEWSWIRE) -- Proto Hologram has expanded rapidly across India, with the launch of AI Avatars of Amitabh Bachchan and Sourav “Dada” Ganguly. Based on IP deals created by Hyderbad-based company Ikonz, the Proto avatars …